KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

NovoCure (NVCR) Accumulated Depreciation & Amortization (2016 - 2025)

NovoCure's Accumulated Depreciation & Amortization history spans 11 years, with the latest figure at $32.3 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 15.56% year-over-year to $32.3 million; the TTM value through Dec 2024 reached $32.3 million, up 15.56%, while the annual FY2024 figure was $32.3 million, 15.56% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $32.3 million at NovoCure, up from $28.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $32.3 million in Q4 2024 and bottomed at $18.4 million in Q4 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $23.6 million (2022), against an average of $24.9 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization grew 25.81% in 2020 before it grew 6.82% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $18.4 million in 2020, then grew by 19.91% to $22.1 million in 2021, then increased by 6.82% to $23.6 million in 2022, then increased by 18.47% to $28.0 million in 2023, then increased by 15.56% to $32.3 million in 2024.
  • Per Business Quant, the three most recent readings for NVCR's Accumulated Depreciation & Amortization are $32.3 million (Q4 2024), $28.0 million (Q4 2023), and $23.6 million (Q4 2022).